Wuxi, China

Jing Hu

This inventor holds 13 USPTO granted patents and 5 published patent applications. Top assignees: Jiangnan University, Max Planck Institute of Colloids and Interfaces. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Hu. Retrieved from https://idiyas.com/inventor/jing-hu-it7jh4bh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 92.3

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jing Hu

Introduction

Jing Hu is a prominent inventor based in Wuxi, China. He has made significant contributions to the field of medicine, particularly in the development of vaccine technologies. With a total of 13 patents, his work has garnered attention for its innovative approaches to immunology.

Latest Patents

One of Jing Hu's latest patents involves the application of heptoglycan-chain-containing oligosaccharide compounds in the preparation of vaccines. This invention focuses on the synthesis of different antigen oligosaccharides, which are fixed onto a chip surface to create a synthetic oligosaccharide chip. Through animal immunization experiments and analysis of the chip, it was determined that the heptoglycan chain serves as a crucial immune epitope. Oligosaccharides containing the α-(1→3) heptoglycan chain can be utilized in the development of vaccines aimed at preventing and treating infections.

Another notable patent is a method for synthesizing the O-antigen saccharide chain of serotype O:6. This method employs seven glycosylation building blocks derived from readily available materials such as D-glucosamine, D-galactose, D-mannose, and L-fucose. The process involves a series of chemical reactions to selectively link these saccharide building blocks, resulting in O-antigen oligosaccharide chains with varying configurations. Additionally, the method includes assembling an amino linker at the reducing end of the O-antigen saccharide chain, allowing for coupling to carrier molecules or immobilization on matrices.

Career Highlights

Jing Hu has held positions at notable institutions, including Jiangnan University and the Max Planck Institute of Colloids and Interfaces. His work at these organizations has contributed to advancements in the field of oligosaccharide research and vaccine development.

Collaborations

Throughout his career, Jing Hu has collaborated with esteemed colleagues, including Jian Yin and Chunjun Qin. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Jing Hu's contributions to the field of medicine through his innovative patents and research collaborations highlight his role as a leading inventor. His work continues to influence vaccine development and immunology, showcasing the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…